Abstract:Histone modifications establish the chromatin states that coordinate the DNA damage response. In this study, we show that SETD2, the enzyme that trimethylates histone H3 lysine 36 (H3K36me3), is required for ATM activation upon DNA double-strand breaks (DSBs). Moreover, we find that SETD2 is necessary for homologous recombination repair of DSBs by promoting the formation of RAD51 presynaptic filaments. In agreement, SETD2-mutant clear cell renal cell carcinoma (ccRCC) cells displayed impaired DNA damage signal… Show more
“…SETD2 protein is responsible for H3K36me3, which may lead to chromatin accessibility changes (23,24) and hinder mismatch repair (MMR) (25), and eventually cause RNA processing defects and promote oncogenesis (26). Previous studies support SETD2's role as a tumor suppressor in ccRCC (27). In our present study, low SETD2 expression was found to be associated with an aggressive phenotype of ccRCC, and was identified as an independent prognostic factor in two independent ccRCC cohorts.…”
“…SETD2 protein is responsible for H3K36me3, which may lead to chromatin accessibility changes (23,24) and hinder mismatch repair (MMR) (25), and eventually cause RNA processing defects and promote oncogenesis (26). Previous studies support SETD2's role as a tumor suppressor in ccRCC (27). In our present study, low SETD2 expression was found to be associated with an aggressive phenotype of ccRCC, and was identified as an independent prognostic factor in two independent ccRCC cohorts.…”
“…Furthermore, SETD2 depletion seemed to favor repair by MMEJ. 24 Importantly, neither SETD2 recruitment nor increased H3K36me3 levels were found at DSBs, [22][23][24][25] suggesting that pre-established H3K36me3 channels active genes to HR repair. Notably, we found that RAD51 recruitment at HR-prone DSBs also depends on the lens epithelium-derived growth factor (LEDGF)/p75, which possesses a PWWP domain for H3K36me3-recognition.…”
Section: Function Of H3k36me3 In Dsb Repair Pathway Choicementioning
confidence: 99%
“…Indeed, we showed that depletion of the main H3K36me3 histone methyltransferase, SETD2, 18 is necessary for HR repair of "HR-prone" DSBs. 22 Concomitantly, 2 other groups reported the critical function of human SETD2 in homologous recombination 23,24 using other experimental systems such as I-SceIand radiation-induced DSBs. Furthermore, SETD2 depletion seemed to favor repair by MMEJ.…”
Section: Function Of H3k36me3 In Dsb Repair Pathway Choicementioning
“…This histone methylation is associated with open heterochromatin and reduced CpG methylation 159,158 , and changes in heterochromatin structure (such as nucleosome rearrangement) can alter the accessibility of the spliceosome machinery to genes and alter the expression of splice-variants. SETD2 mutations could, therefore, change the expression levels and functional structure of many genes 160 . H3K36Me3 is required for serine-protein kinase ATM and TP53-mediated DNA damage checkpoint activation 161 and the recruitment of the DNA mismatch repair protein Msh2 (also called hMutSα) 162 , suggesting that loss of SETD2 function combined with PBRM1 mutations could increase genomic instability and prevent correct cell-cycle checkpoint control.…”
| The majority of kidney cancers are associated with mutations in the von Hippel-Lindau gene and a small proportion are associated with infrequent mutations in other well characterized tumour-suppressor genes. In the past 15 years, efforts to uncover other key genes involved in renal cancer have identified many genes that are dysregulated or silenced via epigenetic mechanisms, mainly through methylation of promoter CpG islands or dysregulation of specific microRNAs. In addition, the advent of next-generation sequencing has led to the identification of several novel genes that are mutated in renal cancer, such as PBRM1, BAP1 and SETD2, which are all involved in histone modification and nucleosome and chromatin remodelling. In this Review, we discuss how altered DNA methylation, microRNA dysregulation and mutations in histone-modifying enzymes disrupt cellular pathways in renal cancers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.